Certified by Founder
Lodge
Biotia
start up
United States
- New York, New York
- 24/08/2022
- Series A
- $8,000,000
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial intelligence for rapid precision infectious disease discovery. Our software and laboratory technology enable clinicians and researchers to guide patient treatment and improve health outcomes.
- Industry Biotechnology Research
- Website https://www.biotia.io/
- LinkedIn https://www.linkedin.com/company/biotia/
Related People
Niamh B. O'HaraCo Founder
United States -
New York, New York,
CEO and co-founder of Biotia, a startup working with hospitals and researchers to leverage high-complexity tests and artificial intelligence for rapid precision infectious disease discovery to guide patient treatment and improve health outcomes.
Vor Systems | $3,000,000 | (Mar 6, 2026)
IntelliGRC | $3,500,000 | (Mar 6, 2026)
Cyclops | $8,000,000 | (Mar 6, 2026)
Lio (formerly askLio) | $30,000,000 | (Mar 6, 2026)
Navigara | $2,500,000 | (Mar 6, 2026)
AgriPass | $7,500,000 | (Mar 6, 2026)
Reclaim Security | $20,000,000 | (Mar 6, 2026)
NextWork | $4,450,000 | (Mar 6, 2026)
Vast | $500,000,000 | (Mar 6, 2026)
Qura | $1,739,595 | (Mar 4, 2026)
Escargot | $2,750,000 | (Mar 4, 2026)
Worldscape | Undisclosed Amount | (Mar 4, 2026)